These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8122512

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding.
    Gleeson N, Devitt M, Sheppard BL, Bonnar J.
    Br J Obstet Gynaecol; 1993 Aug; 100(8):768-71. PubMed ID: 8399019
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia.
    Gleeson NC.
    Am J Obstet Gynecol; 1994 Jul; 171(1):178-83. PubMed ID: 8030696
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. No increased systemic fibrinolysis in women with heavy menstrual bleeding.
    Wiewel-Verschueren S, Knol HM, Lisman T, Bogchelman DH, Kluin-Nelemans JC, van der Zee AG, Mulder AB, Meijer K.
    J Thromb Haemost; 2014 Sep; 12(9):1488-93. PubMed ID: 24954113
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid.
    Bonnar J, Sheppard BL.
    BMJ; 1996 Sep 07; 313(7057):579-82. PubMed ID: 8806245
    [Abstract] [Full Text] [Related]

  • 10. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices.
    Bonnar J, Kasonde K, Haddon M, Hassanein MK, Allington MJ.
    Br J Obstet Gynaecol; 1976 Feb 07; 83(2):160-4. PubMed ID: 148902
    [Abstract] [Full Text] [Related]

  • 11. Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia.
    Rutanen E, Hurskainen R, Finne P, Nokelainen K.
    Fertil Steril; 2000 May 07; 73(5):1020-4. PubMed ID: 10785231
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.
    Ray S, Ray A.
    Cochrane Database Syst Rev; 2014 Nov 26; (11):CD010338. PubMed ID: 25426776
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fibrinogen-fibrin degradation products in menstrual blood from women with normal and excessive menstrual losses.
    Hahn L, Rybo G.
    Acta Obstet Gynecol Scand; 1975 Nov 26; 54(2):119-27. PubMed ID: 1136717
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the Lippes Loop and the Cu-T (200).
    Hefnawi F, Saleh A, Kandil O, El-Sheikha Z, Hassanein M, Askalani H.
    Int J Gynaecol Obstet; 1979 Nov 26; 16(5):400-7. PubMed ID: 35409
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The pathology of dysfunctional uterine bleeding.
    Sheppard BL.
    Clin Obstet Gynaecol; 1984 Apr 26; 11(1):227-36. PubMed ID: 6370534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.